hyperlipidemia,

gallbladder diseases treated pharmacologically,

history of cholestasis unrelated or related to pregnancy,

significant impairment of liver function,

acute or chronic hepatitis,

cirrhosis,

malignant tumor of the liver,

breast cancer (current or past, cured >5 years),

endometrial hyperplasia,

stroke,

meningioma,

lupus with positive titer of antiphospholipid antibodies (or unknown concentration),

thrombophilia-promoting mutations,

congenital or acquired thrombophilia

current or history of thromboembolism (deep vein thrombosis, pulmonary embolism)

ulcerative colitis,

Crohn's disease,

state after organ transplantation,

severe kidney failure,

hereditary angioedema,

hereditary galactose intolerance, lactase deficiency or glucose-galactose malabsorption,

acute sensory disturbances (e.g. visual or hearing impairments),

movement disorders (especially paresis).

47:T422,Are you or have you (within the last four weeks) been treated with any of the following medicines (Note! The names of the active substances are written below, not the medicines themselves. The names of the active substances are always on the medicine packaging, below its trade name): < /b>

phenythion,

primidone,

carbamazepine,

barbiturates,

tomiramate,

oxcarbazepine

rifampicin,

rifabutin,

medicinal products containing ombitasvir, paritaprevir, ritonavir, dasabuv

Contact

Contact us by email

Contact for media